Evidence map›Paper›PMID 40699214›Full record

ArticleeLife2025

Subtypes and proliferation patterns of small intestine neuroendocrine tumors revealed by single-cell RNA sequencing.

Einav Somech, Debdatta Halder, Avishay Spitzer, Chaya Barbolin, Michael Tyler, Reut Halperin, Moshe Biton, Amit Tirosh, Itay Tirosh

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Spatial Transcriptomics Reveals Location-Specific Tumor Cell Subtypes and Signaling within Multifocal Small Intestinal Neuroendocrine Tumors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Einav Somech *Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID https://orcid.org/0000-0002-3665-3105
Debdatta Halder *Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID https://orcid.org/0009-0004-0780-7832
Avishay Spitzer *Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID https://orcid.org/0000-0001-6551-9338
Chaya BarbolinDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Michael TylerDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Reut HalperinENTIRE - Endocrine Neoplasia Translational Research Center, Division of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, and Gray Faculty of Medical and Health Sciences, Tel Aviv University, Ramat Gan, Israel.ORCID https://orcid.org/0000-0002-8137-667X
Moshe BitonDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
Amit TiroshENTIRE - Endocrine Neoplasia Translational Research Center, Division of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, and Gray Faculty of Medical and Health Sciences, Tel Aviv University, Ramat Gan, Israel.ORCID https://orcid.org/0000-0003-3794-9634
Itay TiroshDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID https://orcid.org/0000-0001-5477-2987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine tumors (NETs) occur primarily in the small intestine, lung, and pancreas. Due to their rarity compared to other malignancies in these organs, their complex biology remains poorly understood, including their oncogenesis, tumor composition, and the intriguing phenomena of mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN). Here, we profiled ten low-grade small intestine NET (SiNET) samples as well as one mixed lung tumor by single-cell or single-nuclei RNA-seq. We find that SiNETs are largely separated into two distinct subtypes, in which the neuroendocrine cells upregulate epithelial or neuronal markers, respectively. Surprisingly, in both subtypes, the neuroendocrine cells are largely non-proliferative while higher proliferation is observed in multiple non-malignant cell types. Specifically, B and plasma cells are highly proliferative in the epithelial-like SiNET subtype, potentially reflecting the outcome of high Migration Inhibitory Factor (MIF) expression in those tumors, which may constitute a relevant target. Finally, our analysis of a mixed lung neuroendocrine tumor identifies a population of putative progenitor cells that may give rise to both neuroendocrine and non-neuroendocrine (squamous) cells, potentially explaining the origin of the mixed histology. Taken together, our results provide important insights and hypotheses regarding the biology of neuroendocrine neoplasms.

Indexed as

Cell ProliferationIntestinal NeoplasmsIntestine, SmallNeuroendocrine TumorsHumansMaleSequence Analysis, RNASingle-Cell Analysiscancer biologycell cyclehumanneuroendocrine tumorssingle-cell RNA-seqsmall intestinetumor heterogeneity

Identifiers

PMID40699214
PMCPMC12286602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.